Autologue bone marrow mononuclear cell Therapy (Indonesia University)
- Generic Name
- Autologue bone marrow mononuclear cell Therapy (Indonesia University)
Bone Marrow Mononuclear Cell and Hyperbaric Oxygen Therapy in Diabetes Mellitus
Phase 1
Completed
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- First Posted Date
- 2008-10-07
- Last Posted Date
- 2017-09-21
- Lead Sponsor
- Fuzhou General Hospital
- Target Recruit Count
- 82
- Registration Number
- NCT00767260
- Locations
- 🇨🇳
Fuzhou General Hospital, Fuzhou, Fujian, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath